Clinical trial
Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
NCT00076544 · Elan Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00076544 |
|---|---|
| Title | Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain |
| Official title | An Open-Label, Long-Term, Multi-Center, Intrathecal Ziconotide (PRIALT) Effectiveness and Safety Trial (ZEST) in Patients With Chronic Severe Pain |
| Lead sponsor | Elan Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Ziconotide |
| Enrollment | 300 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2005 |
| First posted | Feb 4, 2004 |
| Last update posted | Dec 14, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: